Healthcare Press

New Treatment Approved for Advanced Melanoma

  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 6 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 34%
  • Publisher: 63%

Health News

Amtagvi,Treatment,Advanced Melanoma

Amtagvi is a T cell immunotherapy for advanced melanoma that cannot be removed with surgery or has spread to other parts of the body. The FDA has fast-tracked its approval to provide early access to patients with limited treatment options.

Amtagvi is a new treatment for patients with advanced melanoma that cannot be removed with surgery or has spread to other parts of the body. It is a T cell immunotherapy that extracts and replicates T cells from a patient's tumor to fight off the cancer.

The FDA has fast-tracked its approval to provide early access to patients with limited treatment options.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 144. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

FDA approves groundbreaking treatment for advanced melanomaErika Edwards is a health and medical news writer and reporter for NBC News and 'TODAY.'
Source: NBCNewsHealth - 🏆 707. / 51 Read more »

FDA Approves First Treatment for Severe FrostbiteThe U.S. Food and Drug Administration (FDA) on Wednesday approved the first treatment for severe frostbite.
Source: MedicineNet - 🏆 575. / 51 Read more »